Preparation, characterization and optimization of sildenafil citrate loaded PLGA nanoparticles by statistical factorial design

DARU, Journal of Pharmaceutical Sciences

Volumn 21, Issue 1, 2013, Pages

  Ghasemian, Elham ^a   Vatanara, Alireza ^a   Rouholamini Najafabadi, Abdolhossein ^a   Rouini, Mohammad Reza ^a   Gilani, Kambiz ^a   Darabi, Majid ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Box Behnken; Double emulsion; Nanoparticle; Optimization; Sildenafil citrate

Indexed keywords

NANOPARTICLE; POLYGLACTIN; POLYVINYL ALCOHOL; SILDENAFIL;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG SCREENING; DRUG SOLUBILITY; DRUG SYNTHESIS; FACTORIAL DESIGN; PARTICLE SIZE; PROCESS OPTIMIZATION; RESPONSE SURFACE METHOD; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE;

EID: 84891769324     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-21-68     Document Type: Article

References (44)

1. Comparison of the solubility and pharmacokinetics of sildenafil salts. Jung SY, Seo YG, Kim GK, Woo JS, Yong CS, Choi HG, Arch Pharm Res 2011 34 451 454 10.1007/s12272-011-0313-y 21547677
2. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist. Webb DJ, Freestone S, Allen MJ, Muirhead GJ, The Am J cardiol 1999 83 21 28
3. Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. Rosano GM, Aversa A, Vitale C, Fabbri A, Fini M, Spera G, Eur Urol 2005 47 214 220 discussion 220-212 10.1016/j.eururo.2004.10.002 15661417 (Pubitemid 40126979)
4. Novel phosphodiesterase-5 inhibitors: current indications and future directions. Sharma R, Indian J Med Sci 2007 61 667 679 10.4103/0019-5359.37789 18174638
5. Molecular mechanisms of pulmonary hypertension. Yildiz P, Clin Chim Acta 2009 403 9 16 10.1016/j.cca.2009.01.018 19361468
6. An old drug for a new application: potential benefits of Sildenafil in wound healing. Farsaie S, Khalili H, Karimzadeh, Dashti-Khavidaki S, J Pharm Pharm Sci 2012 15 483 498 23106952
7. Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart disease. Fraisse A, Butrous G, Taylor MB, Oakes M, Dilleen M, Wessel DL, Intensive Care Med 2011 37 502 509 10.1007/s00134-010- 2065-4 21069290
8. Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles. Elnaggar YS, El-Massik MA, Abdallah OY, Int J Nanomedicine 2011 6 3195 3205 22238508
9. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, et al. Circulation 2009 119 2250 2294 19332472
10. Formulation of sildenafil citrate loaded nasal microsphers: an in vitro, ex vivo characterization. Shah V, Sharma M, Parmar V, Upadhyay U, Int J Drug Del 2010 2 213 220 10.5138/ijdd.2010.0975.0215.02031
11. Ryde TA, Hovey DC, Bosch HW, Novel compositions of sildenafil free base. In Book Novel compositions of sildenafil free base (Editor ed.eds.) City: Google Patents 2004
12. Nanostructured Sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them. Filipcsei G, Otvos Z, Pongrácz K, Darvas F, Book Nanostructured Sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them City: Google Patents 2010
13. Novel compositions of Sildenafil free base. Ryde TA, Hovey DC, Bosch WH, Book Novel compositions of Sildenafil free base City: EP Patent 2008 1,658,053
14. Nanotherapeutics to overcome conventional cancer chemotherapy limitations. Chidambaram M, Manavalan R, Kathiresan K, J Pharm Pharm Sci 2011 14 67 77 21501554
15. Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises. Ungaro F, d'Angelo I, Miro A, La Rotonda MI, Quaglia F, J Pharm Pharmacol 2012 64 1217 1235 10.1111/j.2042-7158.2012.01486.x 22881435
16. Biodegradable polymeric nanoparticles as drug delivery devices. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE, J Control Release 2001 70 1 20 10.1016/S0168-3659(00)00339-4 11166403 (Pubitemid 32144788)
17. Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. Makadia HK, Siegel SJ, Polymers (Basel) 2011 3 1377 1397 10.3390/polym3031377 22577513
18. Studies on bioadhesive PLGA nanoparticles: a promising gene delivery system for efficient gene therapy to lung cancer. Zou W, Liu C, Chen Z, Zhang N, Int J Pharm 2009 370 187 195 10.1016/j.ijpharm.2008.11.016 19073241
19. PLGA-based nanoparticles: an overview of biomedical applications. Danhier F, Ansorena E, Silva JM, Coco R, Le-Breton A, Preat V, J Control Release 2012 161 505 522 10.1016/j.jconrel.2012.01.043 22353619
20. Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells. Mura S, Hillaireau H, Nicolas J, Le-Droumaguet B, Gueutin C, Zanna S, Tsapis N, Fattal E, Int J Nanomedicine 2011 6 2591 2605 22114491
21. In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems. Semete B, Booysen L, Lemmer Y, Kalombo L, Katata L, Verschoor J, Swai HS, Nanomedicine 2010 6 662 671 20230912
22. Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. Lamprecht A, Ubrich N, Hombreiro Perez M, Lehr C, Hoffman M, Maincent P, Int J Pharm 2000 196 177 182 10.1016/S0378-5173(99)00422-6 10699713 (Pubitemid 30105738)
23. A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles. Cohen-Sela E, Chorny M, Koroukhov N, Danenberg HD, Golomb G, J Control Release 2009 133 90 95 10.1016/j.jconrel. 2008.09.073 18848962
24. Sildenafil Citrate. Badwan AA, Nabuls L, Al-Omari MM, Daraghmeh N, Ashour M, Analytical Profiles of Drug Substances and Excipients. Volume 27 Amman, Jordan: Academic Press, Harry GB, 2001 339 376 (Pubitemid 33805292)
25. Optimization of polylactic-co-glycolic acid nanoparticles containing itraconazole using 2(3) factorial design. Prakobvaitayakit M, Nimmannit U, AAPS PharmSciTech 2003 4 71 15198566
26. Nanoparticle design characterized by in silico preparation parameter prediction using ensemble models. Neumann D, Merkwirth C, Lamprecht A, J Pharm Sci 2010 99 1982 1996 19877172
27. Response surface methodology for the optimization of ubiquinone self-nanoemulsified drug delivery system. Nazzal S, Khan MA, AAPS PharmSciTech 2002 3 3 12916956
28. Colloidal gold-loaded, biodegradable, polymer-based stavudine nanoparticle uptake by macrophages: an in vitro study. Basu S, Mukherjee B, Chowdhury SR, Paul P, Choudhury R, Kumar A, Mondal L, Hossain CM, Maji R, Int J Nanomedicine 2012 7 6049 6061 23271908
29. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Higuchi T, J Pharm Sci 1963 52 1145 1149 10.1002/jps.2600521210 14088963
30. Kinetic modeling on drug release from controlled drug delivery systems. Dash S, Murthy PN, Nath L, Chowdhury P, Acta Pol Pharm 2010 67 217 223 20524422
31. Novel paclitaxel nanoparticles: development, in vitro anti-tumor activity in BT-549 cells and in vivo evaluation. Shavi GV, Kumar AR, Karthik A, Naseer M, Aravind G, Praful BD, Reddy MS, Udupa N, J Control Release 2010 148 119 e121 10.1016/j.jconrel.2010.07.091 21529590
32. Experimental design for the optimization of lipid nanoparticles. Zhang J, Fan Y, Smith E, J Pharm Sci 2009 98 1813 1819 10.1002/jps.21549 18781636
33. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Galindo-Rodriguez S, Allemann E, Fessi H, Doelker E, Pharm Res 2004 21 1428 1439 15359578 (Pubitemid 39149658)
34. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization. Beck-Broichsitter M, Kleimann P, Gessler T, Seeger W, Kissel T, Schmehl T, Int J Pharm 2012 422 398 408 10.1016/j.ijpharm.2011.10.012 22001839
35. Preparation and in-vitro evaluation of controlled release PLGA microparticles containing triptoreline. Mahboubian A, Hashemein S, Moghadam S, Atyabi F, Dinarvand R, Iranian J Pharm Res 2010 9 369 378
36. Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. Tewes F, Munnier E, Antoon B, Ngaboni Okassa L, Cohen-Jonathan S, Marchais H, Douziech-Eyrolles L, Souce M, Dubois P, Chourpa I, Eur J Pharm Biopharm 2007 66 488 492 10.1016/j.ejpb.2007.02.016 17433641 (Pubitemid 46756231)
37. Nanoparticles of polyethylene sebacate: a new biodegradable polymer. Guhagarkar SA, Malshe VC, Devarajan PV, AAPS PharmSciTech 2009 10 935 942 10.1208/s12249-009-9284-4 19629708
38. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Yang Y, Chung T, Ng N, Biomaterials 2001 22 231 241 10.1016/S0142-9612(00)00178-2 11197498
39. Evaluation of zidovudine encapsulated ethylcellulose microspheres prepared by water-in-oil-in-oil (w/o/o) double emulsion solvent diffusion technique. Das MK, Rao KR, Acta Pol Pharm 2006 63 141 148 17514878 (Pubitemid 351359771)
40. Effect of formulation and processing variables on the characteristics of tolmetin microspheres prepared by double emulsion solvent diffusion method. Jelvehgari M, Nokhodchi A, Rezapour M, Valizadeh H, Indian J Pharm Sci 2010 72 72 78 10.4103/0250-474X.62251 20582193
41. Microencapsulation of bovine hemoglobin with high bio-activity and high entrapment efficiency using a W/O/W double emulsion technique. Meng FT, Ma GH, Liu YD, Qiu W, Su ZG, Colloids Surf B Biointerfaces 2004 33 177 183 10.1016/j.colsurfb.2003.10.003 (Pubitemid 38183003)
42. Development of a biodegradable nanoparticle platform for sildenafil: formulation optimization by factorial design analysis combined with application of charge-modified branched polyesters. Beck-Broichsitter M, Schmehl T, Gessler T, Seeger W, Kissel T, J Control Release 2012 157 469 477 10.1016/j.jconrel. 2011.09.058 21930166
43. Different biokinetics of nanomedicines linking to their toxicity; an overview. Mostafalou S, Mohammadi H, Ramazani A, Abdollahi M, Daru 2013 22: 21 1 14
44. Current opinion on nanotoxicology. Pourmand A, Abdollahi M, Daru 2012 15: 20 1 95